Arm Limited Patent Portfolio Statistics

tip_user1

Arm Limited

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Arm Limited look like?

Total Applications:	3,056
Granted Patents:	2,494
Grant Index	92.61 %
Abandoned/Rejected Applications:	199 (7.39%)
In-Process Applications:	352
Average Grant Time:	2.86 Years
Average Office Actions:	1.47

Which Technology Area Arm Limited is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
2183	Computer Architecture and I/O	336
2182	Computer Architecture and I/O	164
2824	Semiconductors/Memory	101
2181	Computer Architecture and I/O	100
2827	Semiconductors/Memory	96

How many patents are Arm Limited filing every year?

Year	Total Applications
2022	0*
2021	59*
2020	296
2019	362
2018	347

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Arm Limited in USPTO?

Publication number: –
Application number: 17/285,397

Abstract:
None

Publication date: –
Applicant: Arm Limited
Inventors: Takebe Takanori

Publication number: US20220023201A1
Application number: 17/495,548

Abstract:
This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.

Publication date: 2022-01-27
Applicant: Arm Limited
Inventors: G Michael Parker

Publication number: US20220016094A1
Application number: 17/491,330

Abstract:
A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Publication date: 2022-01-20
Applicant: Arm Limited
Inventors: Michael Myers

How are Arm Limited’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17/285,397	Nutrition Composition	Application Undergoing Preexam Processing	–	–
17/495,548	Phenylephrine Hydrochloride Ready-To-Use Solution	–	OPAP	Central, Docket
17/491,330	Sustained Release Aminopyridine Composition	–	1627	–
17/295,225	Ox40 Antibody, Preparation Method Thereof And Use Thereof	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/480,424	Enzyme Inhibitors	Docketed New Case – Ready for Examination	OPAP	Central, Docket